ProCE Banner Activity

Activity of ADCs in Clinical Trials for Lung Cancer: Anti–TROP-2/CEACAM/c-Met ADCs

Slideset Download
Download these slides from a live CCO Webinar to review the latest clinical trial data on anti–TROP-2, anti-CEACAM, and anti–c-MET ADCs in lung cancer, including ongoing trials evaluating ADC combinations with immunotherapy or third-generation EGFR TKIs.

Released: April 08, 2021

Expiration: April 07, 2022

No longer available for credit.

Share

Faculty

David Planchard

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Paris-Saclay University
International Center for Thoracic Cancers
Villejuif, France

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Paris-Saclay University
International Center for Thoracic Cancers
Villejuif, France